MJ20241102041
This study employed a high-fat diet-induced mouse model to investigate whether mucin treatment affects the composition of the gut microbiota in mice, and to explore the role of the gut microbiota in the alleviation of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) by mucin.